Publications

1. Fluorinated Peptide Hydrogels Result in Longer In Vivo Residence Time after Subcutaneous Administration; Honfroy, A.; Bertouille, J.; Turea, A.-M.; Cauwenbergh, T.; Bridoux, J.; Lensen, N.; Mangialetto, J.; Van den Brande, N.; White, J., F.; Gardiner, J.; Brigaud, T.; Ballet, S.; Hernot, S.; Hernot, S.; Chaume, G.; Martin, C. Biomacromolecules, 2024, ASAP
 

2. Expanding 1-Aminosugar Synthesis through Activated Glycals' Reactivity; Li, L.; Lemouton, E.; Al Ayi, Y.; Ryzhakov, D.; Retailleau, P.; Messaoudi, S.; Ferry, A.; Eur. J. Org. Chem, 2024, e202400728
 

3. L-PBF processing and characterization of a Ti₃₅Nb₃₀Zr₂₉Mo₃Ta₃ multiprincipal element alloy for medical implants; Arjmand, F.; Mourgout, A.; Chali, A.; Djemai, M.; Langueh, C.-Y.; Monasson, O.; Peroni, E.; Boissiere, M.; Ammar-Merah, S.; Dirras, G.; Appl. Phys. Lett., 2024, 125, 041904

4. Incorporation of CF₃-pseudoprolines into polyproline type II foldamers confers promising biophysical features, Cayrou, C.; Walrant, A.; Ravault, D.; Guitot, K.; Noinville, S.; Sagan, S.; Brigaud, T.; Gonzalez, S.; Ongeri, S.; Chaume, G.; Chem.Commun., 2024, 60, 8609-8612.

5. 1-Iodoglycal: a versatile intermediate for the synthesis of D-glyco amides and esters employing carbonylative cross-coupling reaction, Hornink, M., M.; Toledo, M., F., Z., J.; Pimenta, D., C.; Paschoalin, C.; Silva, P. M.; Figlino, G., E.; Aguiar, E.; Cervi, G.; Ribeiro, F., W., M.; Correra, TH., C.; Ferry, A.; Stefani, H., A.; ACS Omega, 2024, 9, 29, 31732–31744.

 
6. Asymmetric α-Fluoroalkyl-α-Amino Acids: Recent Advances in Their Synthesis and Applications, Picois, N.; Boutahri, Y.; Milbeo, P.; Zanato, C.; Lensen, N.; Chaume, G.; Brigaud, T.; Molecules, 2024, 29(6), 1408

7. Bimodal use of chiral α-Trifluoromethylalanine in Aib Foldamers: study of the position impact towards the helical screw-sense preference, Picois, N.; Bodero, L.; Milbeo, P.; Brigaud, T.; Chaume, G.; Chem.Eur.J., 2024, e202400540

8. 3D printing of gellan-dextran methacrylate IPNs in glycerol and their bioadhesion by RGD derivatives, Paoletti, L.; Baschieri, F.; Migliorini, C.; Di Meo, C.; Monasson, O.; Peroni, E.; Matricardi, P.; J. Biomed. Mater. Res., 2024;ASAP.

9. N-linked glycosylation of the M-protein variable region : glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma, Langerhorst, P.;Baerenfaenger, M.; Kulkarni, P.; Nadal, S.; Wijnands, C.; Post, M.A.; Noori, S.; vanDuijn, M.M.; Joosten I.; Dejoie, T.; van Gool, A.J.; Gloerich, J.; Lefeber, D.J.; Wessels H.J.C.T.; Jacobs, J.F.M.; Clinical Chemistry and Laboratory Medicine (CCLM), 2024, ASAP.

10. Synthesis and biological evaluation of selective Pepstatin based trifluoromethylated inhibitors of Cathepsin D, Terzani, F.; Belhattab, S.; Le Guern, A.; Guitot, K.; Monasson, O.; Zanato, C.; Chelain, E.; Leroy-Dudal, J.;Pytkowicz, J.; Eur. J. Med. Chem., 2024, 116178 (OpenAccess) 

11. Developments in the chemistry and biology of 1,2,3-triazolyl-C-nucleosides, Rodrigues do Nascimento, S., M.; Ferry, A.; Gallier, F.; Lubin-Germain, N.; Uziel, J.; Gonzales, S.; Soter de Mariz e Miranda, L.; Arch. Pharm., 2024, e2300580

12. Directed copper-catalyzed dehydrogenative C–H amination of unsaturated sialic acids, Li, L.; Ferry, A.; Messaoudi, S.; Org. Chem. Front., 2024, 11, 466-471

2024-2021   2020-2016   2015-2011   2010-2002